Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
2009 NOV 23 ... model of filgrastim and pegfilgrastim application in normal mice and those with cyclophosphamide-induced granulocytopaenia.' According to recent research from Leipzig, Germany, ...
2009 NOV 23 ... in the journal Cell Proliferation report. "Healthy rats and those with cyclophosphamide-induced neutropenia were treated with either pegfilgrastim or Maxy-G34 under various ...
2009 NOV 23 ... by the ELISpot technique. Longevity of ovalbumin-specific plasma cells was determined by cyclophosphamide treatment, which depletes proliferating plasmablasts but leaves plasma cells untouched. ...
2009 NOV 23 ... (COX-2) protein abundance in urothelium/suburothelium of bladders of mice subsequent to cyclophosphamide (CYP)-induced bladder inflammation. We also used primary cultures of human urothelial ...
2009 NOV 23 ... for 14 days. On day 15, DNA damage was induced by intra-peritoneal (i.p.) injection of cyclophosphamide (CP) (i.p.) at 50 mg/kg b.w. after the MN test and comet assay were performed. A ...
2009 NOV 24 ... cells and in the superficial urothelial cells that undergo differentiation following cyclophosphamide-induced regeneration, in correlation with urothelial cell differentiation. In normal ...
2009 NOV 23 ... also acquired resistance to standard chemotherapy agents like Taxol, Doxorubicin, and Cyclophosphamide," wrote S.P. Fessler and colleagues. The researchers concluded: "Acquired ...
2009 NOV 23 ... Research findings, 'Preventive effect of piperonyl butoxide on cyclophosphamide-induced teratogenesis in rats,' are discussed in a new report. According to a study ...
2009 NOV 23 ... and IgM antibodies were determined by nephelometry and ELISA assays. prednisone (PDN), cyclophosphamide (CYC), methotrexate (MTX), mycophenolate mofetil (MMF) and azathioprine (AZA) decreased ...
2009 NOV 24 ... to investigate the effects of l-arginine (Arg) on performance and immune function in cyclophosphamide (CY) immunosuppressed weaned pigs. The weaned pigs were allotted randomly into one of ...
2009 NOV 23 ... detail in 'Effects of lipopolysaccharide on the induction of mixed chimerism in cyclophosphamide-induced tolerance,' new data in immunology. ...
2009 NOV 23 ... 60% of patients with diffuse large B-cell lymphoma (DLBCL) will be cured with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP). However, the outcome following ...
2009 NOV 23 ... Scientists discuss in 'Addition of rituximab to cyclophosphamide, doxorubicin, vincristine, and prednisolone therapy has a high risk of developing ...
2009 NOV 23 ... However, his I-123-metaiodobenzylguanidine scintigraphy was negative; therefore, the cyclophosphamide, vincristine, and dacarbazine (CVD) combination chemotherapy was initiated. The ...
2009 NOV 16 ... first-line, follicular CD20-positive non Hodgkins lymphoma after first-line CVP (cyclophosphamide, vincristine, prednisone) therapy. About PRIMA The PRIMA study ...
2009 NOV 16 ... on days 1-7 in combination with standard-dose docetaxel (Taxotere), Adriamycin and cyclophosphamide (TAC) on day 5 as preoperative chemotherapy in 28 patients with T2-4 tumors. Effects of ...
2009 NOV 23 ... of ifosfamide. It is expected to overcome the resistance seen with ifosfamide and cyclophosphamide, two of the most commonly used alkylating drugs used to treat certain cancers. ...
2009 NOV 23 ... of ifosfamide. It is expected to overcome the resistance seen with ifosfamide and cyclophosphamide, two of the most commonly used alkylating drugs used to treat certain cancers. ...
